Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Game on: mobile app helps kids fight kidney disease

NCT ID NCT07162220

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 27 times

Summary

This study tested whether a mobile game app could help children aged 11-14 with chronic kidney failure better manage their condition. 68 children were split into two groups: one played the game, the other received standard education. Researchers measured changes in BMI, blood pressure, knowledge about kidney disease, healthy lifestyle beliefs, and attitudes toward illness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILD, ONLY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Akdeniz University

    Antalya, Konyaaltı, 07070, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mobile game app

What this could lead to

If it works, this could give doctors and families a fun, low-cost tool to help children learn about managing their kidney condition.

What could go wrong

This is a small, completed trial with only 68 children. The game may not improve actual health outcomes, and results may not apply to all kids with kidney failure.

Conditions

The condition(s) this trial relates to.

CHILD syndrome chronic kidney disease disease pathological gambling

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.